Pro Share Advisors LLC Vericel Corp Transaction History

Pro Share Advisors LLC

$46.4 Billion
Q3 2025

A detailed history of Pro Share Advisors LLC transactions in Vericel Corp stock. As of the latest transaction made, Pro Share Advisors LLC holds 11,292 shares of VCEL stock, worth $450,099. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,292

Previous 13,127 13.98%

Holding current value

$450,099

Previous $558,000 36.38%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 05, 2025	SELL	$29.84 - $41.74 $54,756 - $76,592	-1,835 Reduced 13.98%	11,292 $355,000
Q2 2025 Aug 07, 2025	SELL	$37.92 - $45.7 $26,392 - $31,807	-696 Reduced 5.04%	13,127 $558,000
Q1 2025 May 08, 2025	SELL	$44.5 - $61.8 $147,784 - $205,237	-3,321 Reduced 19.37%	13,823 $616,000
Q4 2024 Feb 13, 2025	BUY	$40.05 - $59.11 $165,206 - $243,828	4,125 Added 31.68%	17,144 $941,000
Q3 2024 Nov 13, 2024	BUY	$42.25 - $53.56 $112,723 - $142,898	2,668 Added 25.78%	13,019 $550,000

Q2 2024 Aug 13, 2024	SELL	$41.71 - $52.9 $109,864 - $139,338	-2,634 Reduced 20.28%	10,351 $474,000
Q1 2024 May 08, 2024	BUY	$32.52 - $52.33 $32,357 - $52,068	995 Added 8.3%	12,985 $675,000
Q4 2023 Feb 14, 2024	BUY	$30.85 - $37.09 $146,321 - $175,917	4,743 Added 65.45%	11,990 $426,000
Q3 2023 Nov 13, 2023	SELL	$31.69 - $39.25 $5,989 - $7,418	-189 Reduced 2.54%	7,247 $242,000
Q2 2023 Aug 10, 2023	BUY	$29.0 - $38.37 $17,197 - $22,753	593 Added 8.67%	7,436 $279,000
Q1 2023 May 11, 2023	BUY	$23.85 - $31.34 $163,205 - $214,459	6,843 New	6,843 $200,000
Q2 2022 Aug 01, 2022	SELL	$22.88 - $39.45 $236,785 - $408,268	-10,349 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$31.69 - $43.29 $40,531 - $55,367	-1,279 Reduced 11.0%	10,349 $395,000
Q4 2021 Feb 08, 2022	BUY	$35.2 - $52.6 $157,203 - $234,911	4,466 Added 62.36%	11,628 $457,000
Q3 2021 Nov 12, 2021	SELL	$46.35 - $59.75 $285,516 - $368,060	-6,160 Reduced 46.24%	7,162 $350,000
Q2 2021 Aug 13, 2021	SELL	$47.2 - $67.81 $8,779 - $12,612	-186 Reduced 1.38%	13,322 $699,000
Q1 2021 May 14, 2021	BUY	$30.93 - $59.48 $106,275 - $204,373	3,436 Added 34.11%	13,508 $750,000
Q4 2020 Feb 09, 2021	BUY	$18.53 - $31.5 $186,634 - $317,268	10,072 New	10,072 $311,000

Others Institutions Holding VCEL

# of Institutions

274

Shares Held

52.6M

Call Options Held

36.6K

Put Options Held

9.1K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $1.88B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Vericel Corp Transaction History